Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody.
about
Novel Bifunctional Cyclic Chelator for (89)Zr Labeling-Radiolabeling and Targeting Properties of RGD ConjugatesAdvances in immuno-positron emission tomography: antibodies for molecular imaging in oncologyPET imaging with ⁸⁹Zr: from radiochemistry to the clinicInvestigation of Zr(IV) and 89Zr(IV) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging.In Vitro and In Vivo Comparison of Selected Ga-68 and Zr-89 Labelled Siderophores.(89)Zr, a radiometal nuclide with high potential for molecular imaging with PET: chemistry, applications and remaining challenges.Radiometals: towards a new success story in nuclear imaging?Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2×Anti-HSG Bispecific Antibody and a (177)Lu-Labeled Peptide.Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody.Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human.Rational Design, Development, and Stability Assessment of a Macrocyclic Four-Hydroxamate-Bearing Bifunctional Chelating Agent for 89 Zr.The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target.
P2860
Q35676322-CCCB6FD1-19C8-4622-B705-87826DB57703Q36339722-44347DED-1D25-41C6-B143-2B91232ED87CQ36454584-379020AB-E150-4DB7-9138-52E19025CD41Q36514149-C08F4F7B-116C-4485-B1EB-97DBBA6A5101Q36909826-E6D01042-1373-44D3-A8D7-7B6AC1A5987DQ38111973-DF50D288-671B-468B-B394-799CC76B1FB2Q38273277-0CD3F746-80AA-4EE9-B184-5FD31C042E99Q38956099-616732CE-C976-492E-A30C-35585EE6D6ADQ39151986-C833CBC6-9065-4393-88BD-767010EAD3FEQ41874340-7C7EF762-AA92-4EBB-977A-1D4BD32E6CC9Q48719577-F2218EE5-4E54-4263-AB1D-32EE5CDD6BD5Q55508847-39F48115-61D7-414D-A2F8-48AE47ED4223
P2860
Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Imaging of prostate cancer wit ...... nti-EGP-1 monoclonal antibody.
@ast
Imaging of prostate cancer wit ...... nti-EGP-1 monoclonal antibody.
@en
Imaging of prostate cancer wit ...... nti-EGP-1 monoclonal antibody.
@nl
type
label
Imaging of prostate cancer wit ...... nti-EGP-1 monoclonal antibody.
@ast
Imaging of prostate cancer wit ...... nti-EGP-1 monoclonal antibody.
@en
Imaging of prostate cancer wit ...... nti-EGP-1 monoclonal antibody.
@nl
prefLabel
Imaging of prostate cancer wit ...... nti-EGP-1 monoclonal antibody.
@ast
Imaging of prostate cancer wit ...... nti-EGP-1 monoclonal antibody.
@en
Imaging of prostate cancer wit ...... nti-EGP-1 monoclonal antibody.
@nl
P2093
P1476
Imaging of prostate cancer wit ...... nti-EGP-1 monoclonal antibody.
@en
P2093
Catharina M van Rij
Cathelijne Frielink
David M Goldenberg
Gerben M Franssen
Janneke D M Molkenboer
Robert M Sharkey
Wietske M van Weerden
Wim J G Oyen
P304
P356
10.2967/JNUMED.110.086520
P407
P577
2011-08-24T00:00:00Z